Search

Your search keyword '"Lymphomas -- Genetic aspects"' showing total 609 results

Search Constraints

Start Over You searched for: Descriptor "Lymphomas -- Genetic aspects" Remove constraint Descriptor: "Lymphomas -- Genetic aspects"
609 results on '"Lymphomas -- Genetic aspects"'

Search Results

3. 'Proteolysis Targeting Chimeras And Methods Of Use Thereof' in Patent Application Approval Process (USPTO 20240293557)

4. National Cancer Institute (NCI) Researcher Discusses Research in B-Cell Lymphoma (Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients)

5. 'Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias' in Patent Application Approval Process (USPTO 20240228655)

6. New Mantle Cell Lymphoma Data Have Been Reported by Investigators at University of Texas MD Anderson Cancer Center (Tp53 Mutation Is Frequent In Mantle Cell Lymphoma With Ezh2 Expression and Have Dismal Outcome When Both Are Present)

8. Emory University Winship Cancer Institute Researcher Highlights Research in Cancer Gene Therapy (Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells)

11. Investigators from University of Basel Zero in on B-Cell Lymphoma (Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-cell Lymphoma: Real-life Experience With 74 Cases)

12. Investigators at Postgraduate Institute of Medical Education and Research Report Findings in Gene Therapy (Recurrent Mutations In Refractory/relapsed Diffuse Large B-cell Lymphoma By Targeted Gene Sequencing)

13. Medical miracle: Man cured of HIV and cancer

14. My fear of the cancer gene will never go away -- but after my double mastectomy I can finally move on; My mother died aged 35 of breast cancer -- the new NHS BRCA screening programme for people with Jewish ancestry may have saved her life

15. New Squamous Cell Carcinoma Research Reported from Hefei (Lung Squamous Cell Carcinoma with EML4-ALK Fusion and TP53 Co-mutation Treated with Ensartinib: A Case Report and Literature Review)

16. A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma

17. A Genetic and Immunohistochemical Analysis of H. Pylori Phenotypes and p27 expression in Adenocarcinoma Patients in Jordan (Updated December 20, 2022)

20. Reports from Catholic University of Louvain (UCLouvain) Advance Knowledge in Lung Cancer (Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma)

21. Researcher at National Clinical Research Center for Blood Diseases Targets Mantle Cell Lymphoma (Proteogenomic Features Define Novel Subtypes of Mantle Cell Lymphoma)

22. March Biosciences Awarded $13.4 Million by CPRIT to Advance Its CD5 CAR-T Therapy for T-cell Lymphoma in Phase 2 Trials

23. 'Genetically Engineered T Cells With Disrupted Casitas B-Lineage Lymphoma Proto-Oncogene-B (Cblb) And Uses Thereof' in Patent Application Approval Process (USPTO 20230346836)

24. Borrowing Transcriptional Kinases to Activate Apoptosis

25. 'Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias' in Patent Application Approval Process (USPTO 20230331864)

28. Researchers at University Hospital Carl Gustav Carus Target Lymphoma (Recurrent Germline Variant in * * RAD21* * Predisposes Children to Lymphoblastic Leukemia or Lymphoma)

29. RadGenNets: Deep Learning-Based Radiogenomics Model For Gene Mutation Prediction In Lung Cancer (Updated April 18, 2022)

30. LUNGevity Launches New ALK Patient Gateway

31. Increased frequencies of IgH locus suicide recombination points on Chronic Lymphocytic Leukemia with low rate of AID related somatic mutations, cMYC overexpression and short telomeres

32. Research on Cancer Research Published by Researchers at Oncology Institute of Southern Switzerland (Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post ...)

33. Data on B-Cell Lymphoma Described by Researchers at Boston University (Early progression and transformation of a splenic diffuse red pulp small B-cell lymphoma with NOTCH1, ARID2, CREBBP, and TNFRSF14 gene mutations)

34. University of Wurzburg Researchers Provide Details of New Studies and Findings in the Area of Mycosis Fungoides (Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the ...)

35. Eisai introduces Tazverik tablets 200mg in Japan to treat r/r EZH2 gene mutation-positive follicular lymphoma

36. Findings in Lymphoma Reported from National Cancer Institute (NCI) [Sinularamides A-g, Terpenoid-derived Spermidine and Spermine Conjugates With Casitas B-lineage Lymphoma Proto-oncogene B (Cbi-b) Inhibitory Activities From a Sinularia Sp. Soft ...]

37. Researchers at Department of Laboratory Medicine Target Transcription Factors (Resistance Mutations To Btk Inhibitors Originate From the Nf-kappa B but Not From the Pi3k-ras-mapk Arm of the B Cell Receptor Signaling Pathway)

38. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies

39. Research from Shanghai Institute of Hematology in the Area of B-Cell Lymphoma Published (Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma)

40. Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation

41. Hainan University Researchers Detail Findings in Initiator Caspases (Molecular characterization and expression analysis of B-cell lymphoma-2 in Trachinotus ovatus and its role in apoptotic process)

42. New Lung Cancer Study Findings Recently Were Reported by Researchers at Zhejiang Provincial Hospital of Traditional Chinese Medicine (Novel MRPS9-ALK Fusion Mutation in a Lung Adenocarcinoma Patient: A Case Report)

43. Eisai's Tazverik gets Japanese marketing approval to treat r/r EZH2 gene mutation-positive follicular lymphoma

44. Study Data from Dana-Farber Cancer Institute Update Knowledge of Hematology Research (Cbl Mutations Drive Pi3k/akt Signaling Via Increased Interaction With Lyn and Pik3r1)

45. Studies from Department of Pathology Further Understanding of Lymphoma (Case Report: EBV-Positive Extra-Nodal Marginal Zone Lymphoma Associated With XMEN Disease Caused by a Novel Hemizygous Mutation in MAGT1)

46. SCIENTISTS MAP GENETIC EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO RICHTER'S SYNDROME

48. New Cancer Study Findings Recently Were Reported by Researchers at Rigshospitalet [Protein Phosphatase, Mg2+/mn2+-dependent 1d (Ppm1d) Mutations In Haematological Cancer]

49. Research from Tokai University Provide New Insights into B-Cell Lymphoma (Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma)

Catalog

Books, media, physical & digital resources